The compositional and structural characteristics of the solid represent the spatial physicochemical factors with implications for potential temporal chemical and physical effects. Characterizing these properties may be used to establish the initial and final state of a solid with respect to a process which may be connected to product quality and performance. These properties partially define expectations of stability, dissolution, and bioavailability, which in turn relate to safety and efficacy.
Occasionally particles exist with disordered, amorphous, molecular structure. Most frequently ordered systems exist that are defined by uniform distances between adjacent molecules that define the general morphology of the crystal system. However, the particle appearance may vary based on constraints of crystal growth or the presence of impurities.
- 1.Hickey A, Ganderton D. Pharmaceutical process engineering. 2nd ed. New York: Informa Healthcare; 2010.Google Scholar
- 5.Mullin J. Crystallization. 3rd ed. Oxford, UK: Butterworth-Heinemann; 1993.Google Scholar
- 6.Carstensen J. Pharmaceutical principles of solid dosage forms. Lancaster: Technomic Publishing Company; 1993.Google Scholar
- 7.Administration UFaD. Guidance for industry: Q8(R2) pharmaceutical development: US Department of Health and Human Services. Washington, DC; 2009.Google Scholar
- 9.Zimon A, Volkova T. Effect of surface roughness on dust adhesion. Colloid J USSR. 1965;27:306–7. (English Translation)Google Scholar
- 10.Pietsch W. Agglomerate bonding and strength. In: Fayed M, Otten L, editors. Handbook of powder science and technology. New York: Van Nostrand Reinhold; 1984. p. 231–52.Google Scholar